Which type of chromosomal mosaicism is compatible for embryo transfer: a systematical review and meta-analysis
- PMID: 35306582
- DOI: 10.1007/s00404-022-06511-6
Which type of chromosomal mosaicism is compatible for embryo transfer: a systematical review and meta-analysis
Abstract
Purpose: Chromosomal mosaicism becomes a common phenomenon in Preimplantaion genetic testing (PGT). This meta-analysis was conducted to study which feature of chromosomal mosaicism was compatible for embryo transfer.
Methods: After searching the database PubMed, Embase, CCTR and related reviews up until May 2021. Two reviewers extracted relevant information and assessed study quality by the Newcastle-Ottawa scale independently. Summary Odd Radios (OR) were calculated using fixed- or random-effects models for clinical outcomes. A network meta-analysis compared the clinical outcomes of different chromosomes.
Results: A total of six studies with 1,106 cycles of single mosaic embryo transferred were included. Significant results of implantation rate (IR), miscarriage rate (MR), and ongoing pregnancy/live birth rate (OP/LBR) were observed when comparing embryos with mosaicism level < 50% and ≥ 50% [OR 1.42, 95% CI (1.06, 1.89); OR 0.45, 95% CI (0.27, 0.75); OR 1.74, 95% CI (1.28, 2.37)], and embryos with mosaicism with only affecting segmental chromosome(s) and only involving whole chromosome(s) [OR 1.31, 95% CI (1.01, 1.71); OR 0.57, 95% CI (0.36, 0.93); OR 1.51, 95% CI (1.15, 2.00)]. Embryos with only mosaic gains or losses had significant higher IR and OP/LBR than complex mosaicism [Gains vs complex: OR 1.75, 95% CI (1.20, 2.54); OR 1.73, 95% CI (1.16, 2.58). Losses vs complex: OR 1.90, 95% CI (1.34, 2.71); OR 2.10, 95% CI (1.44, 3.07)]. Mosaic embryos with only one chromosome involved had significant favorable outcomes of IR and OP/LBR than with three or more chromosomes involved [OR 1.76, 95% CI (1.23, 2.52); OR 1.86, 95% CI (1.25,2.78)]. Chr. 7, Chr. 2, Chr. 1, Chr. 18, Chr. 11, Chr. X, Chr. 13, Chr. 14, Chr. 12, and Chr. 9 were considered as prioritized chromosomes of mosaic embryos for transfer.
Conclusions: This analysis support the embryos with mosaicism level ≥ 50%, whole chromosome(s) involved, multiple mosaic abnormalities were associated with worse pregnancy outcomes. Mosaicism level of 50% could be used as a threshold to assess the mosaic embryos.
Keywords: Chromosomal mosaicism; Clinical outcomes; In vitro fertilization; Neonatal outcomes; Preimplantation genetic testing for aneuploidy.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Munne S, Weier HU, Grifo J, Cohen J (1994) Chromosome mosaicism in human embryos. Biol Reprod 51:373–379. https://doi.org/10.1164/rccm.201909-1836OC - DOI - PubMed
-
- Taylor TH, Gitlin SA, Patrick JL, Crain JL, Wilson JM, Griffin DK (2014) The origin, mechanisms, incidence and clinical consequences of chromosomal mosaicism in humans. Hum Reprod Update 20:571–581. https://doi.org/10.1093/humupd/dmu016 - DOI - PubMed
-
- Practice C, Genetic Counseling Professional Group of the American Society for Reproductive Medicine. Electronic address aao. Clinical management of mosaic results from preimplantation genetic testing for aneuploidy (PGT-A) of blastocysts: a committee opinion. Fertil Steril 2020;114:246–54. Doi: https://doi.org/10.1016/j.fertnstert.2020.05.014 .
-
- Lin PY, Lee CI, Cheng EH et al (2020) Clinical outcomes of single mosaic embryo transfer: high-level or low-level mosaic embryo, does it matter? J Clin Med 9(6):1695. https://doi.org/10.3390/jcm9061695 - DOI - PMC
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
